Navigation Links
Immucor Appoints Chief Operating Officer
Date:7/16/2009

NORCROSS, Ga., July 16 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that Geoffrey S. Crouse has been named Vice President and Chief Operating Officer.

In this newly created position, Mr. Crouse will have worldwide responsibility for manufacturing and distribution as well as sales, marketing and customer service. Mr. Crouse will report to Dr. Gioacchino De Chirico, Immucor's President and Chief Executive Officer.

Mr. Crouse previously served as vice president of the life sciences business at Millipore Corporation, a NYSE-traded provider of technologies, tools and services for the global life science industry. In this role, he led the Life Science Strategic Business Unit, a global laboratory consumables and reagents business, and held responsibility for manufacturing, research and development, sales and marketing. During his tenure, Mr. Crouse improved manufacturing operations, led multiple acquisitions and integrations while increasing sales and profitability for the business unit.

"We are pleased to strengthen our management team with the addition of Geoff," stated Dr. De Chirico. "His experience and results-oriented track record will enhance our efforts to improve transfusion medicine through automation. Our commitment to improving blood bank operations and patient safety benefits our customers, employees and shareholders."

Mr. Crouse's experience includes various leadership roles in both the U.S. and internationally. Prior to joining Millipore, Mr. Crouse worked at Roche, a Swiss Exchange-traded leader in the pharmaceuticals and diagnostics industries, where he most recently led market development and government affairs for the diagnostics division based in Basil, Switzerland.

Mr. Crouse holds a Masters of Business and a Masters of Public Health from the University of California, Berkeley as well as a Bachelor of Arts degree from Boston College.

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.


'/>"/>
SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
2. Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009
3. Immucor Announces Fiscal Year 2010 Guidance
4. Immucor to Announce Fiscal 2010 Guidance on Monday, June 1, 2009
5. Immucor to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
6. Immucor Receives Subpoena From Department of Justice
7. Immucor Announces Fiscal Third Quarter Results
8. Immucor Announces New Vice President, Operations
9. Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
10. Immucor Closes BioArray Acquisition
11. Immucor Schedules Fiscal 2009 Guidance Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 2016 , ... California Senate Bill (SB) 863, signed into law in 2012, ... and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition , a ... study, medical payments per claim in California decreased 4 percent in 2013 and then ...
(Date:12/8/2016)... San Francisco, California (PRWEB) , ... December 08, 2016 , ... ... health coaches, has raised an $18M Series B led by Canvas Ventures . ... use the capital to scale its mobile platform to serve more consumers who are ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... services from offices headquartered in Jefferson County, is announcing the launch of a ... Birmingham. , The number of homeless women and children in Birmingham has grown ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Compretta Insurance Agency, a family ... in and around the Hancock County area, is announcing the launch of a charity ... , The Hancock County Food Pantry has worked for more than 30 years to ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication to ... of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of ... both sides of the Atlantic with a mechanism to comply with EU data protection ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Pennsylvania Physician General ... Drug and Alcohol Programs Gary Tennis ... medications, known as benzodiazepines, developed with the help ... are medications that are frequently prescribed for anxiety ... are used with opioid pain medications, benzodiazepines pose ...
(Date:12/8/2016)... Dec. 8, 2016 True Health Diagnostics ... leading-edge laboratory services and management expertise to hospital ... , allowing more doctors and patients to benefit ... solutions. Logo - http://photos.prnewswire.com/prnh/20161208/447162LOGO ... systems, under pressure to contain costs, have struggled ...
(Date:12/8/2016)... NORWALK, Connecticut , 8. Dezember 2016 Mederi Therapeutics Inc ... Stretta-Therapie – eine nicht-operative Behandlungsmethode für gastroösophageale Refluxerkrankung (GERD) – in ... Reading ... Live ... by Professor Jun Liu, Director of Endoscopy at Wuhan Union Hospital ...
Breaking Medicine Technology: